Hailed by some as miracle drugs, GLP-1s have surged in popularity in the past few years. An estimated one out of every eight Americans is now on some version of them and scientists continue to research new potential uses. But with that rapid expansion, there's a growing list of questions and…
Weight loss jabs helped one Auckland woman change her drinking habits after losing 30kg.
La primera medida para despejar este panorama es darle al GLP el lugar estratégico que le corresponde en la transición energética como combustible prioritario por su confiabilidad, competitividad y capacidad de respuesta
MANASSAS, Va., Oct. 3, 2026 /PRNewswire/ -- As GLP-1 medications reshape how millions of people eat, a quieter question is getting far less attention: what happens to nutrition when appetite drops sharply? PureHealth Research is addressing that gap directly, with a collection built around...
Despite many other benefits that have emerged, people are mainly on it to shed pounds — including one demographic in particular, whose use of the drug has skyrocketed from .8% in 2018 to 1.9% in 2025 — a 24-fold increase.
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.
